Almaject
Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees
Almaject is a pharmaceutical manufacturer focused on the development, acquisition, and commercialization of injectable generic products. Its portfolio spans a broad range of therapeutic areas, and the company pursues opportunities to expand into more complex molecules through its commercial, business development, and R&D activities. Based in Pine Brook, New Jersey, Almaject operates as a U.S. subsidiary of Alvogen, a privately held global organization with a network of manufacturing and development hubs across the United States, Romania, Korea, and Taiwan. The firm targets customers seeking injectable generics and related pharmaceutical products, addressing needs in markets that require diverse therapeutic options. Almaject positions itself within the generic and biosimilar pharmaceutical landscape by advancing a pipeline and portfolio that can evolve with its parent company’s broader global presence.